Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats

Pharmacological Reports

Volumn 63, Issue 4, 2011, Pages 1040-1049

  Folwarczna, Joanna ^a   Pytlik, Maria ^a   Śliwiński, Leszek ^a   Cegieła, Urszula ^a   Nowińska, Barbara ^a   Rajda, Monika ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bone histomorphometry; Bone mechanical properties; Bone mineralization; Prednisolone; Propranolol

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE SODIUM SUCCINATE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DISEASE; BONE MASS; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIAPHYSIS; DRUG EFFICACY; EXPERIMENTAL DESIGN; FEMUR; FEMUR NECK; GLUCOCORTICOID INDUCED OSTEOPOROSIS; LONG BONE; LUMBAR VERTEBRA; MALE; METAPHYSIS; MORPHOMETRICS; NONHUMAN; RAT; TIBIA;

EID: 80053343618     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70620-X     Document Type: Article

References (42)

1. Baek K, Bloomfield SA: β-Adrenergic blockade and leptin replacement effectively mitigate disuse bone loss. J Bone Miner Res, 2009, 24, 792-799.
2. 3 adrenoceptors. Br J Pharmacol, 2005, 144, 317-322.
3. Bonnet N, Beaupied H, Vico L, Dolleans E, Laroche N, Courteix D, Benhamou CL: Combined effects of exercise and propranolol on bone tissue in ovariectomized rats. J Bone Miner Res, 2007, 22, 578-588. (Pubitemid 47457435)
4. Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, Eder V, Pichon C, Courteix D: Low dose β-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol, 2008, 217, 819-827.
5. Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, Benhamou CL: Protective effect of β blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone, 2007, 40, 1209-1216. (Pubitemid 46553796)
6. Bonnet N, Laroche N, Vico L, Dolleans E, Benhamou CL, Courteix D: Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats. J Pharmacol Exp Ther, 2006, 318, 1118-1127. (Pubitemid 44274974)
7. Bonnet N, Pierroz DD, Ferrari SL: Adrenergic control of bone remodelling and its implications for the treatment of osteoporosis. J Musculoskelet Neuronal Interact, 2008, 8, 94-104.
8. Bouxsein ML, Devlin MJ, Glatt V, Dhillon H, Pierroz DD, Ferrari SL: Mice lacking β-adrenergic receptors have increased bone mass, but are not protected from deleterious skeletal effects of ovariectomy. Endocrinology, 2009, 150, 144-152.
9. Canalis E, Mazziotti G, Giustina A, Bilezikian JP: Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int, 2007, 18, 1319-1328. (Pubitemid 47389469)
10. Compston J: Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol, 2010, 6, 82-88.
11. De Nijs RNJ: Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. Minerva Med, 2008, 99, 23-43.
12. De Vries F, Souverein PC, Cooper C, Leufkens HG, van Staa TP: Use of β-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int, 2007, 80, 69-75. (Pubitemid 46294972)
13. Elefteriou F: Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys, 2008, 473, 231-236.
14. Folwarczna J, Janiec W, Firlus K, Kaczmarczyk-Sedlak I: Effects of doxycycline on the development of bone damage caused by prednisolone in rats. Pol J Pharmacol, 1999, 51, 243-251. (Pubitemid 29245576)
15. Folwarczna J, Janiec W, Gawor M, Pytlik M, Kaczmarczyk-Sedlak I, Nowińska B: Effects of enoxaparin on histomorphometric parameters of bones in rats. Pol J Pharmacol, 2004, 56, 451-457. (Pubitemid 39585899)
16. Folwarczna J, Janiec W, Śliwiński L: Effects of heparin and low-molecular-weight heparins on bone mechanical properties in rats. Thromb Haemost, 2004, 92, 940-946. (Pubitemid 39545515)
17. Folwarczna J, Śliwiński L, Kulig M, Nowińska B, Cegieła U, Pytlik M, Kaczmarczyk-Sedlak I, Trzeciak HI: Effect of propranolol on the glucocorticoid-induced bone changes in young rats. Calcif Tissue Int, 2007, 80, Suppl 1, S126-S127 (abstract).
18. Graham S, Hammond-Jones D, Gamie Z, Polyzois I, Tsiridis E, Tsiridis E: The effect of β-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing. Expert Opin Investig Drugs, 2008, 17, 1281-1299.
19. HamrickMW, Ferrari SL: Leptin and the sympathetic connection of fat to bone. Osteoporos Int, 2008, 19, 905-912. (Pubitemid 351758616)
20. Kamel HK: Male osteoporosis: new trends in diagnosis and therapy. Drugs Aging, 2005, 22, 741-748.
21. Lelovas PP, Xanthos TT, Thoma SE, Lyritis GP, Dontas IA: The laboratory rat as an animal model for osteoporosis research. Comp Med, 2008, 58, 424-430.
22. Levasseur R, Sabatier JP, Potrel-Burgot C, Lecoq B, Creveuil C, Marcelli C: Sympathetic nervous system as a transmitter of mechanical loading in bone. Joint Bone Spine, 2003, 70, 515-519. (Pubitemid 38029805)
23. Meisinger C, Heier M, Lang O, Döring A: β-Blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study. Osteoporos Int, 2007, 18, 1189-1195. (Pubitemid 47300270)
24. Minkowitz B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ: Effects of propranolol on bone metabolism in the rat. J Orthop Res, 1991, 9, 869-875.
25. Ogoshi T, Hagino H, Fukata S, Tanishima S, Okano T, Teshima R: Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry. Mod Rheumatol, 2008, 18, 552-561.
26. Okabe H, Higashi T, Ohta T, Hashimoto Y: Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation. Biol Pharm Bull, 2004, 27, 1422-1427. (Pubitemid 41701686)
27. Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E, Nicholson GC: β-Adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong osteoporosis study. J Bone Miner Res, 2004, 19, 19-24. (Pubitemid 41295133)
28. Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC: β-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res, 2005, 20, 613-618. (Pubitemid 40393069)
29. Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen K, Mosekilde L: Fracture risk in perimenopausal women treated with β-blockers. Calcif Tissue Int, 2004, 75, 365-372. (Pubitemid 40100883)
30. Rejnmark L, Vestergaard P, Mosekilde L: Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens, 2006, 24, 581-589. (Pubitemid 43261923)
31. Sato T, Arai M, Goto S, Togari A: Effects of propranolol on bone metabolism in spontaneously hypertensive rats. J Pharmacol Exp Ther, 2010, 334, 99-105.
32. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR: Use of β-blockers and risk of fractures. JAMA, 2004, 292, 1326-1332.
33. Stürmer EK, Seidlová-Wuttke D, Sehmisch S, Rack T, Wille J, Frosch KH, Wuttke W, Stürmer KM: Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res, 2006, 21, 89-96.
34. Śliwiński L, Folwarczna J, Kaczmarczyk-Sedlak I, Pytlik M, Cegieła U, Trzeciak HI: Effects of propranolol on the skeletal system of non-ovariectomized and ovariectomized rats. Calcif Tissue Int, 2008, 82, Suppl 1, S224-S225 (abstract).
35. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G: Leptin regulates bone formation via the sympathetic nervous system. Cell, 2002, 111, 305-317. (Pubitemid 35345151)
36. Takeda S, Karsenty G: Molecular bases of the sympathetic regulation of bone mass. Bone, 2008, 42, 837-840.
37. Togari A, Arai M: Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption. J Pharmacol Sci, 2008, 106, 542-546. (Pubitemid 351556230)
38. Ton FN, Gunawardene SC, Lee H, Neer RM: Effects of low-dose prednisone on bone metabolism. J Bone Miner Res, 2005, 20, 464-470. (Pubitemid 40293495)
39. Turner CH, Burr DB: Basic biomechanical measurements of bone: a tutorial. Bone, 1993, 14, 595-608. (Pubitemid 23198821)
40. van Brussel MS, Bultink IEM, Lems WF: Prevention of glucocorticoid- induced osteoporosis. Expert Opin Pharmacother, 2009, 10, 997-1005.
41. Wiens M, Etminan M, Gill SS, Takkouche B: Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med, 2006, 260, 350-362. (Pubitemid 44370908)
42. Zhang W, Kanehara M, Zhang Y, Wang X, Ishida T: β-Blocker and other analogous treatments that affect bone mass and sympathetic nerve activity in ovariectomized rats. Am J Chin Med, 2007, 35, 89-101. (Pubitemid 46206525)